Opportunity and innovation for pharma, biotechs, healthcare and investors - World Vaccine Congress & Expo Washington 2013

FREE seminars and conferences

To reserve your place at the FREE seminars and conferences taking place all over and throughout the event, just click the titles that interest you to view the full day's line-up. Then check those you want to attend. Your selections are automatically saved and you can open and close as many sessions as you like. Your selections are automatically saved as part of your registration for the event.

You can register for as many sessions as you like. Just click "Register FREE now" when you've made your selection
DAY 1
Theatre 1: Manufacturing
Theatre 1 on Tuesday 16 Apr 2013
TIME
PRESENTATION
SPONSORED BY
REGISTER
10:30
Break
 
11:00
Vivalis- Licensing cell line technologies for vaccine production
Louis Cantolupo, Director, Business Development, Vivalis
11:30
IDT Biologika- Expansion of contract manufacturing services
Andreas Neubert, Vice President Vaccines, IDT Biologika
12:00
BioReliance by SAFC- Massively Parallel Sequencing in Vaccine Production and Product Safety
John L. Kolman, Ph.D., Executive Director, Global Head of Genomic Services, BioReliance
12:30
Break
 
13:00
Baxter BioPharma Solutions- Using a service provider to overcome global challenges in vaccine manufacturing & delivery
Kelly Davis, Associate Director, Regulatory Affairs and Tom Tsilipetros, Product/Market Manager, Baxter BioPharma Solutions
13:50
Break
 
14:20
Break
 
14:50
SynCo Bio Partners- Factors and considerations for selecting and managing the outsourced GMP project
James Harris, Business Development Manager, SynCo Bio Partners
15:20
Aeras- Spray dried powder vaccine: How far will it advance into clinical trials?
Dr Tom Jin, Senior Scientist, Aeras
15:50
Break
 
DAY 1
Theatre 2: Research
Theatre 2 on Tuesday 16 Apr 2013
TIME
PRESENTATION
SPONSORED BY
REGISTER
10:30
VaxNet- Strategic collaboration between vaccine site networks and CRO's/Pharma
Debra Gabrielson, Chief Operating Officer, VaxNet and Bruce Bowling, Medical Director, VaxNet
11:00
Cellular Technology Limited- Challenges and successes of measuring antigen-specific T-Cell response
Dr Magdalena Tary-Lehmann, Chief Scientific Officer, Cellular Technology Limited
11:30
Quintiles Outcome- Managing large vaccine programs: Lessons from around the globe
Vicky Leamy, MPH, Therapeutic Strategy Lead, Infectious Diseases and Vaccines, Quintiles Outcome
12:00
RPS Inc.- A Project Managers Perspective on Large Scale Vaccine Trials
Avi Collins: Project Manager, RPS Inc.
12:30
Eurocine Vaccines - Immunose™ FLU – a new influenza vaccine candidate for children
Dr Hans Arwidsson, Chief Executive Officer, Eurocine Vaccines
13:00
Elite Research Networks-Key components of successful vaccine development: Investigative site perspectives
Chris Hoyle, Executive Director, Elite Research Networks and Jean Blackburn, President, Advanced Clinical Research
13:50
Break
 
14:20
Break
 
14:50
Wuxi Apptec- Strategies for adventitious agent detection in viral vaccines
Dr Heather Malicki, Scientific Director, Virology Technology Development, Wuxi Apptec
15:20
ERA Consulting Group- Regulatory strategies for taking vaccine development to Europe
Dr Chris Holloway, Group Director of Regulatory Affairs, ERA Consulting Group
15:50
Retroscreen- Human viral challenge trials: Over a decade of experience and over 1,000 volunteers safely inoculated - What have we learned?
Dr Rob Lambkin-Williams, CSO, Retroscreen
DAY 1
Theatre 3: Tools & Services
Theatre 3 on Tuesday 16 Apr 2013
TIME
PRESENTATION
SPONSORED BY
REGISTER
10:30
Break
 
11:00
Break
 
11:30
EMD Millipore- Providing global access to vaccines is a team effort
Christophe Couturier, Vice President, EMD Millipore
12:00
Pfenex- Rapid antigen production in pseudomonas fluorescens utilizing a high-throughput, parallel processing approach
William Taylor, Director, Business Development & Commercial Operations
12:30
UTMB- Vaccine development: From the bench to the bedside and beyond
Dr Bridget Hawkins, Assistant Director, Sealy Center for Vaccine Development, UTMB
13:00
CSL- Administration of influenza vaccine by needle free jet injector : a joint effort from PharmaJet Inc and CSL Ltd
Dr Linda McAllister, Chief Medical Officer, PharmaJet Inc.
13:50
Break
 
14:20
Break
 
14:50
West Pharmaceutical Services- Improving outcomes with intradermal injection guide
Zach Marks, Director of Strategic Marketing, West Pharmaceutical Services
15:20
Virocyt- Influenza vaccine manufacturing
On behalf of Virocyt
Agnès Hardy-Boyer and Jonathan Haines, Manufacturing Technology, Industrial Operation Directors, Sanofi Pasteur US
15:50
SGS Belgium NV- Viral challenge testing for vaccine development in a phase I clinical pharmacology unit
Dr Robert Lins, Senior Clinical Adviser - Clinical Research, SGS Belgium NV
DAY 2
Theatre 1: Research & Manufacturing
Theatre 1 on Wednesday 17 Apr 2013
TIME
PRESENTATION
SPONSORED BY
REGISTER
10:30
KBI BioPharma- Analytical Challenges for Recombinant Protein Vaccines
Dr Tim Kelly, Vice President, Biopharmaceutical Development, KBI BioPharma
11:00
Break
 
11:30
ABL- Increased antibody breadth following immunization with an HIV-1 envelope-based DNA prime/protein boost vaccine
Dr Anthony Cristillo, Associate Director, Product Development, ABL
12:00
Vibalogics- Fixed-bed bioreactors: The future of adherent cell-based virus production? Case studies
Dr Kai Lipinski, Head of Process Development, Vibalogics
12:30
AbMax- Speedy developments of sandwich ELISA kits for vaccine development
Dr Le Sun, CEO & President, AbMax
13:00
Novasep- Viral vector production: the solution of a one-stop-shop CMO
Sophie Hallez, Project Director, Novasep
13:50
Break
 
14:20
Break
 
DAY 2
Theatre 2: Tools & Services
Theatre 2 on Wednesday 17 Apr 2013
TIME
PRESENTATION
SPONSORED BY
REGISTER
10:30
Focus Diagnostics- Correlates of vaccine-induced immunity: Emphasis on Influenza and Flaviviruses
Dr Keith Gottlieb, Manager, Research and Development, Focus Diagnostics
11:00
Break
 
11:30
Refine Technology- Case study - Boosting viral production
Earl Pineda, Product Manager, Refine Technology
12:00
Alpha Diagnostic- Simple and direct measurement of active vaccine components adsorbed on Alhydrogel
Dr Ali Masarrat, Director R&D, Alpha Diagnostic
12:30
Finesse- Implementing seamless transfer of control solutions from small-scale to large-scale manufacturing through Smart single-use technology
Dr Barbara Paldus, CEO, Finesse
13:00
Rapid Micro Bio- The role of automated, non-destructive microbial detection and enumeration in quality control
Mark Severns, Marketing Manager, Rapid Micro Bio
13:50
Corium International Inc. - MicrCor® - Needle Free Transdermal Technology for Vaccine Delivery
Dr Bobby Singh, Chief Technology Officer and VP, R&D
14:20
Break